Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jing Zhao"'
Autor:
Duo Yang, Xiaoli Wang, Xinna Zhou, Jing Zhao, Huabing Yang, Shuo Wang, Michael A. Morse, Jiangping Wu, Yanhua Yuan, Sha Li, Amy Hobeika, Herbert Kim Lyerly, Jun Ren
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Human microbiota influence the response of malignancies to treatment with immune checkpoint blockade; however, their impact on other forms of immunotherapy is poorly understood. This study explored the effect of blood microbiota on clinical efficacy,
Externí odkaz:
https://doaj.org/article/f08c4a0a824844c3909df4d8abff9757
Autor:
Jia He, Jun-Zhong Lin, J. Yang, Qiu-Zhong Pan, Yan Tang, Shi-Ping Chen, Qijing Wang, Jian-Chuan Xia, Yongqiang Li, Meng-Jia Song, Chaopin Yang, Jia-Mei Gu, De-Sheng Weng, Jing Jing Zhao, Yue Huang, Yu Qing Zhou
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
Adjuvant chemotherapy after surgery is the standard treatment modality for stage III and part of stage II or stage IV colorectal cancer (CRC) patients. However, the 5-year overall survival (OS) rate remains unsatisfactory. Thus, developing combinatio
Autor:
Zi Qi Zhou, Qi Jing Wang, Fang Jian Zhou, Rui Qing Peng, Qian Zhu, Zhi Ling Zhang, Yuan Liu, Li Juan Jiang, Chang Long Chen, Chuan Miao Xie, Yan Tang, Jia He, Minshan Chen, De Sheng Weng, Qiu Zhong Pan, Xiao-Fei Zhang, Dan Dan Li, Ying Wang, Jing Jing Zhao, Jian Chuan Xia
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Cytokine-induced killer (CIK) cells that are stimulated using mature dendritic cells (DCs), referred to as (DC-CIK cells) exhibit superior anti-tumor potency. Anti-programmed death-1 (PD-1) antibodies reinvigorate T cell-mediated antitumor immunity.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qian Zhu, Jian Chuan Xia, Zi Qi Zhou, Jing Jing Zhao, Jiang Xue Wu, Lu Ping Yuan, Ying Wang, Qiu Zhong Pan, Xiao-Fei Zhang, Chun Yu Huang, Yan Tang, De Sheng Weng, Chang Long Chen
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Interleukin (IL)-17 has been reported to play a controversial role in tumor immunity. Our previous studies showed that infiltration of IL-17-producing cells in esophageal squamous cell carcinoma (ESCC) induced tumor protective immunity by recruiting
Autor:
Shi Ping Chen, Xiao dong Li, Jian Chuan Xia, Li Xi Huang, Jia He, Jing Jing Zhao, De Sheng Weng, Yong Qiang Li, Li Zhang, Qiu Zhong Pan, Yi Xin Zeng, Qi Jing Wang, Yan Tang, Qing Liu, Miao La Ke
Publikováno v:
Oncoimmunology. 4(9)
Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis. In this study, we investigated the efficacy of a sequential combination of autologous cellular immunotherapy (CIT) and chemotherapy for pos
Autor:
Mu Yan Cai, De Sheng Weng, Hao Hu, Min Li, Jing Jing Zhao, Chang Long Chen, Jian Chuan Xia, Huan Xin Lin, Ling Guo, Qian Zhu
Publikováno v:
OncoImmunology, Vol 6, Iss 5 (2017)
Programmed death ligand 1 (PD-L1) expression represents a mechanism of immune escape by inhibiting T cell immunity. This study systematically evaluated the expression of PD-L1, spatial distribution of CD3+ immune cells and the relationship of both fa
Autor:
Chang-Long Chen, Qiu-Zhong Pan, De-Sheng Weng, Chuan-Miao Xie, Jing-Jing Zhao, Min-Shan Chen, Rui-Qing Peng, Dan-Dan Li, Ying Wang, Yan Tang, Qi-Jing Wang, Zhi-Ling Zhang, Xiao-Fei Zhang, Li-Juan Jiang, Zi-Qi Zhou, Qian Zhu, Jia He, Yuan Liu, Fang-Jian Zhou, Jian-Chuan Xia
Publikováno v:
OncoImmunology; Apr2018, Vol. 7 Issue 4, p1-10, 10p
Autor:
Qiu-Zhong Pan, Jing-Jing Zhao, Chao-Pin Yang, Yu-Qing Zhou, Jun-Zhong Lin, Yan Tang, Jia-Mei Gu, Qi-Jing Wang, Yong-Qiang Li, Jia He, Shi-Ping Chen, Meng-Jia Song, Yue Huang, Jie-Ying Yang, De-Sheng Weng, Jian-Chuan Xia
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Adjuvant chemotherapy after surgery is the standard treatment modality for stage III and part of stage II or stage IV colorectal cancer (CRC) patients. However, the 5-year overall survival (OS) rate remains unsatisfactory. Thus, developing combinatio
Externí odkaz:
https://doaj.org/article/808971fc44914db7b98dbeeccb0665b0
Autor:
Chang-Long Chen, Ying Wang, Chun-Yu Huang, Zi-Qi Zhou, Jing-Jing Zhao, Xiao-Fei Zhang, Qiu-Zhong Pan, Jiang-Xue Wu, De-Sheng Weng, Yan Tang, Qian Zhu, Lu-Ping Yuan, Jian-Chuan Xia
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Interleukin (IL)-17 has been reported to play a controversial role in tumor immunity. Our previous studies showed that infiltration of IL-17-producing cells in esophageal squamous cell carcinoma (ESCC) induced tumor protective immunity by recruiting
Externí odkaz:
https://doaj.org/article/b968d98bbd7b422dae5bdeeb803306be